Veeva Systems Past Earnings Performance
Past criteria checks 2/6
Veeva Systems has been growing earnings at an average annual rate of 14.9%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 19.7% per year. Veeva Systems's return on equity is 11.3%, and it has net margins of 22.2%.
Key information
14.9%
Earnings growth rate
13.1%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 19.7% |
| Return on equity | 11.3% |
| Net Margin | 22.2% |
| Last Earnings Update | 31 Jan 2024 |
Recent past performance updates
Recent updates
Veeva Systems: Strong Reasons To Buy And Hold The Shares
Apr 18Earnings Tell The Story For Veeva Systems Inc. (NYSE:VEEV)
Apr 15
Veeva Systems: A Jewel In Transition
Mar 28Veeva Systems: Still Attractively Priced Given Growth Expectations
Mar 13Veeva: Growth Prospects Have Improved, But Stock Price May Be Capped
Mar 05Do Veeva Systems' (NYSE:VEEV) Earnings Warrant Your Attention?
Feb 15Veeva Systems (NYSE:VEEV) May Have Issues Allocating Its Capital
Jan 28Veeva Systems: Well Positioned To Consolidate Share In The Industry
Jan 24Veeva: Downside Risks Driven By Slowing Revenue, Uncertain Product Adoption And Increasing Competition
Jan 08Veeva Systems: A Recovery Might Be Sooner Than Later
Dec 22Veeva Systems Q3 Preview: Navigating Challenges And Opportunities For F2025
Nov 29Is There Now An Opportunity In Veeva Systems Inc. (NYSE:VEEV)?
Nov 29Veeva: Some Underappreciated Growth Opportunities
Oct 20Veeva Systems' (NYSE:VEEV) Returns On Capital Not Reflecting Well On The Business
Oct 16Veeva Systems: A Lot Of Growth Opportunities Remain
Oct 03Estimating The Intrinsic Value Of Veeva Systems Inc. (NYSE:VEEV)
Oct 02Veeva Systems: Its Strong Moat Might Extend To The SMB Sector
Sep 21Veeva Systems: A Close Look At Its Evolving Valuation
Sep 01Do Veeva Systems' (NYSE:VEEV) Earnings Warrant Your Attention?
Sep 01Should You Investigate Veeva Systems Inc. (NYSE:VEEV) At US$201?
Jul 31Veeva Systems: Cloud Dominance Counters Competition
Jul 26Capital Allocation Trends At Veeva Systems (NYSE:VEEV) Aren't Ideal
Jul 13Veeva Systems: Richly Priced For What It Offers
Jul 05Are Veeva Systems Inc. (NYSE:VEEV) Investors Paying Above The Intrinsic Value?
Jun 13Veeva Systems: AI Potential For Life Sciences Underappreciated
Jun 12Veeva Systems: Strengths Shine Through With Q1 Results
Jun 02Veeva Systems: Keep An Eye On The Following Things
May 23What Does Veeva Systems Inc.'s (NYSE:VEEV) Share Price Indicate?
May 02Veeva Systems (NYSE:VEEV) May Have Issues Allocating Its Capital
Apr 14Should You Be Adding Veeva Systems (NYSE:VEEV) To Your Watchlist Today?
Mar 17Veeva Systems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Mar 04Veeva Systems downgraded by Guggenheim on worries estimates are too high
Feb 23Veeva Systems: A Leading Provider Of Cloud-Based Solutions For The Pharmaceutical Industry
Jan 30Estimating The Intrinsic Value Of Veeva Systems Inc. (NYSE:VEEV)
Jan 24What Does Veeva Systems Inc.'s (NYSE:VEEV) Share Price Indicate?
Jan 09Veeva Systems: The Stock Is Not Expensive
Dec 30The Returns On Capital At Veeva Systems (NYSE:VEEV) Don't Inspire Confidence
Nov 26Veeva Systems: An Ambitious Goal Within Reach
Nov 09Veeva: Niche SaaS Doesn't Hit The Mark For Me
Oct 25What Is Veeva Systems Inc.'s (NYSE:VEEV) Share Price Doing?
Oct 08Veeva: A Dip Not Worth Buying
Oct 06Are Investors Undervaluing Veeva Systems Inc. (NYSE:VEEV) By 33%?
Sep 23Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Veeva Systems makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jan 24 | 2,364 | 526 | 628 | 629 |
| 31 Oct 23 | 2,296 | 567 | 618 | 608 |
| 31 Jul 23 | 2,232 | 540 | 605 | 577 |
| 30 Apr 23 | 2,176 | 519 | 593 | 554 |
| 31 Jan 23 | 2,155 | 488 | 566 | 520 |
| 31 Oct 22 | 2,077 | 396 | 543 | 483 |
| 31 Jul 22 | 2,001 | 394 | 512 | 451 |
| 30 Apr 22 | 1,922 | 412 | 478 | 412 |
| 31 Jan 22 | 1,851 | 427 | 460 | 382 |
| 31 Oct 21 | 1,762 | 433 | 437 | 359 |
| 31 Jul 21 | 1,663 | 424 | 415 | 340 |
| 30 Apr 21 | 1,562 | 409 | 397 | 315 |
| 31 Jan 21 | 1,465 | 380 | 384 | 294 |
| 31 Oct 20 | 1,380 | 343 | 378 | 273 |
| 31 Jul 20 | 1,283 | 329 | 359 | 246 |
| 30 Apr 20 | 1,196 | 314 | 334 | 227 |
| 31 Jan 20 | 1,104 | 301 | 305 | 210 |
| 31 Oct 19 | 1,025 | 306 | 271 | 191 |
| 31 Jul 19 | 969 | 288 | 257 | 179 |
| 30 Apr 19 | 911 | 259 | 244 | 167 |
| 31 Jan 19 | 862 | 230 | 235 | 159 |
| 31 Oct 18 | 816 | 199 | 225 | 153 |
| 31 Jul 18 | 768 | 170 | 212 | 147 |
| 30 Apr 18 | 726 | 158 | 200 | 141 |
| 31 Jan 18 | 691 | 151 | 189 | 132 |
| 31 Oct 17 | 655 | 132 | 183 | 121 |
| 31 Jul 17 | 620 | 119 | 175 | 112 |
| 30 Apr 17 | 584 | 93 | 171 | 103 |
| 31 Jan 17 | 551 | 78 | 159 | 97 |
| 31 Oct 16 | 508 | 65 | 159 | 91 |
| 31 Jul 16 | 472 | 54 | 149 | 83 |
| 30 Apr 16 | 439 | 54 | 135 | 75 |
| 31 Jan 16 | 409 | 54 | 120 | 66 |
| 31 Oct 15 | 382 | 50 | 105 | 58 |
| 31 Jul 15 | 359 | 50 | 97 | 51 |
| 30 Apr 15 | 336 | 46 | 91 | 45 |
| 31 Jan 15 | 313 | 40 | 86 | 41 |
| 31 Oct 14 | 289 | 33 | 82 | 37 |
| 31 Jul 14 | 260 | 25 | 76 | 33 |
| 30 Apr 14 | 234 | 17 | 70 | 30 |
| 31 Jan 14 | 210 | 10 | 62 | 26 |
| 31 Oct 13 | 187 | 6 | 52 | 23 |
| 31 Jul 13 | 168 | 4 | 42 | 20 |
| 30 Apr 13 | 148 | 7 | 34 | 17 |
Quality Earnings: VEEV has high quality earnings.
Growing Profit Margin: VEEV's current net profit margins (22.2%) are lower than last year (22.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VEEV's earnings have grown by 14.9% per year over the past 5 years.
Accelerating Growth: VEEV's earnings growth over the past year (7.8%) is below its 5-year average (14.9% per year).
Earnings vs Industry: VEEV earnings growth over the past year (7.8%) did not outperform the Healthcare Services industry 15.4%.
Return on Equity
High ROE: VEEV's Return on Equity (11.3%) is considered low.